The Biopharmaceutical and Biomedicine market is estimated to be valued at US$ 20025.57 Bn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The biopharmaceutical and biomedicine market comprises of products such as biosimilars, monoclonal antibodies, vaccines,...